Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Trimesta (Oral Estriol)
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study.
Morphogenesis of the demyelinating lesions in Baló's concentric sclerosis.
More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
Switch to natalizumab vs fingolimod in active relapsing-remitting multiple sclerosis.
Evaluation of quality of life and fatigue in radiologically isolated syndrome.
Multiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon-β Includes Upregulation of TLR7 in Plasmacytoid Dendritic Cells.
Zebrafish as a model to investigate CNS myelination.
Myelin in cartilaginous fish.
Teriflunomide in multiple sclerosis: Added benefit not proven
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapse Remitting Multiple Sclerosis
LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons.
Treatment with Trichuris suis soluble products during monocyte-to-macrophage differentiation reduces inflammatory responses through epigenetic remodeling.
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA TM*) in Multiple Sclerosis
Altered intra- and interregional synchronization in relapsing-remitting multiple sclerosis: a resting-state fMRI study.
Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity.
A Complex Case of Neuro-Behçet's Disease in a Patient Previously Diagnosed with multiple Sclerosis: A Case Report.
Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature.
Burden of neurological conditions in Canada.
Alkali metals levels in the human brain tissue: Anatomical region differences and age-related changes.
Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
Synaptic pathology: a shared mechanism in neurological disease.
Treatment Burden and Chronic Illness: Who is at Most Risk?
Beta-Interferon, Glatiramer Acetate Cost-Effective in MS

Pages